BRAF signaling pathway and targeted therapies in the BRAF pathway

The BRAF signaling pathway and targeted therapies in the BRAF pathway. Description: Binding of ligands to transmembrane receptors, such as FGFR or EGFR, leads to receptor dimerization and phosphorylation of kinases, which leads to the recruitment of growth factor receptor-bound protein 2 (GRB2) to the phosphorylated receptor. The attachment of Son of Sevenless (SOS—GTP exchange factor) to GRB2 enables the activation of RAS-GDP to RAS-GTP. The active form of RAS-GTP causes downstream activation of MAPK, PI3K, and other effector pathways. BRAF inhibitors in yellow box and MEK inhibitors in blue box inhibit BRAF and MEK substrates and inhibit downstream pathway activation
BRAF signaling pathway and targeted therapies in the BRAF pathway

Publication

Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers (2024) Khine S. Shan, et al. Int J Mol Sci. 2024 Jan;25(1). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates GRB2 GRB2 ncbigene_symbol GRB2 2885
Homo sapiens Primates RAS-GTP RAS famplex_relations KRAS 3845
Homo sapiens Primates RAS-GTP RAS famplex_relations HRAS 3265
Homo sapiens Primates RAS-GTP RAS famplex_relations NRAS 4893
Homo sapiens Primates BRAF BRAF ncbigene_symbol BRAF 673
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates MEK MEK ncbigene_synonym MAP2K7 5609
Homo sapiens Primates MEK MEK famplex_relations MAP2K1 5604
Homo sapiens Primates MEK MEK famplex_relations MAP2K2 5605
Homo sapiens Primates mTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates ERK ERK ncbigene_synonym EPHB2 2048
Homo sapiens Primates ERK ERK ncbigene_synonym MAPK1 5594
Homo sapiens Primates ERK ERK famplex_relations MAPK3 5595

Chemical mentions

Word Match MeSH Name ChEBI
Ligands ligands chebi:52214
effector effector effector chebi:35224
Vemurafenib vemurafenib N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide chebi:63637
Dabrafenib dabrafenib N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide chebi:75045
DAY101 DAY101 6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide chebi:167672
MEK MEK butan-2-one chebi:28398
Trametinib trametinib N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide chebi:75998
Binimetinib binimetinib 5-(4-bromo-2-fluoroanilino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide chebi:145371
Cobimetinib cobimetinib bis[(2S)-2-{1-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzoyl]-3-hydroxyazetidin-3-yl}piperidin-1-ium] (2E)-but-2-enedioate chebi:90853

Disease mentions

Word Match MeSH Name DOID